Viewing Study NCT02019069


Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2026-02-22 @ 12:42 AM
Study NCT ID: NCT02019069
Status: COMPLETED
Last Update Posted: 2019-01-22
First Post: 2013-11-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Sponsor: Rondeep Brar
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: IRB-28524
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View